Levosalbutamol Nebulized Inhalation Solution generally refers to Levosalbutamol Hydrochloride Nebulized Inhalation Solution, the main ingredient of which is Levosalbutamol Hydrochloride. In clinical practice, it is commonly used for the treatment or prevention of bronchospasm, and common adverse reactions include tachycardia, diarrhea, and dizziness. Levosalbutamol Hydrochloride Nebulized Inhalation Solution is a kind of asthma medication used in clinical practice, and it is more used in respiratory department. The main ingredient of levosalbutamol hydrochloride nebulized inhalation solution is levosalbutamol hydrochloride, which can be used for the treatment or prevention of bronchospasm phenomenon caused by reversible airway obstructive diseases in people aged 12 years and above. In clinical practice, some patients may experience adverse reactions such as tachycardia, diarrhea, dry mouth, dizziness, and worsening of cough after using this medication; if the patient’s adverse reactions are severe, he/she needs to inform the doctor promptly. If patients have allergy to levosalbutamol or racemic salbutamol, levosalbutamol hydrochloride nebulized inhalation solution is prohibited to prevent accidents. Patients are advised to use this drug under the guidance of a doctor and not to change the dosage of the drug without authorization, otherwise it may induce cardiac arrest and hypoxia.